California’s Life Science Slams Drug Price Cap, Warns of Innovation Crisis
Here is the rewritten content in HTML Syntax:
```html
A San Diego life sciences startup. Courtesy CONNECT
California's life science industry announced on Tuesday the devastating impact that federal price controls on pharmaceuticals would have on medical innovation.
This statement was made by Biocom California following the release of a list…